UROWAVE

FDA Premarket Approval P970044 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a manufacturing site located at dornier medizintechnik gmbh, argeisrieder feld 7, d-82234 wessling, germany.

DeviceUROWAVE
Generic NameSystem, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy
ApplicantDornier MedTech America, Inc.
Date Received1999-02-02
Decision Date1999-03-12
PMAP970044
SupplementS003
Product CodeMEQ 
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonLocation Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Dornier MedTech America, Inc. 1155 Roberts Blvd. kennesaw, GA 30144

Supplemental Filings

Supplement NumberDateSupplement Type
P970044Original Filing
S003 1999-02-02 Normal 180 Day Track
S002 1998-06-30 Real-time Process
S001 1998-06-15 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.